Explore by Category

IMW: Defining High Risk Multiple Myeloma Today and Into the Future

MYELOMA NEWS - September 09, 2021

At the International Myeloma Workshop in Vienna, French researcher Herve Avet-Louiseu, MD, PhD shared a presentation about how he sees high risk myeloma to... Read More

The International Myeloma Workshop Opens in Vienna

MYELOMA NEWS - September 08, 2021

“Just imagine what we will see as we move these therapies up front,” pondered International Myeloma Society (IMS) President Nikhil Munshi about... Read More

FDA Clears Application for First Off-the-Shelf CAR T in Multiple Myeloma

MYELOMA NEWS - September 02, 2021

The first off-the-shelf CAR T targeting BCMA has received FDA clearance to begin clinical trials. This week the FDA approved an investigational new drug applica... Read More

FDA Grants Orphan Disease Designation for Multiple Myeloma Oral IKZF1/3 Inhibitor

MYELOMA NEWS - August 19, 2021

A new class of drug that selectively destroys myeloma-causing proteins through degradation has received Orphan Disease Designation from the FDA for multiple mye... Read More

FDA Approves Booster COVID Shot for Immunocompromised Individuals

MYELOMA NEWS - August 16, 2021

Last week the U.S. Food and Drug Administration approved the use of a third booster shot of either the Pfizer-BioNTech or Moderna COVID0-19 vaccine for immunoco... Read More

FDA Approval for Shingrix to Prevent Shingles Post Auto Stem Cell Transplant Transplant in Multiple Myeloma

MYELOMA NEWS - August 09, 2021

The title of this article actually short-changes the recent supplemental FDA approval of Shingrix, and I would like to rectify that right away. The full supplem... Read More

Darzalex FasPro Receives FDA Approval for Use with Pomalidomide and Dex in Multiple Myeloma

MYELOMA NEWS - August 04, 2021

Darzalex Faspro, the subcutaneous 5 minute shot version of daratumumab, has been FDA approved for use with pomalidomide and dexamethasone for multiple myeloma p... Read More

Response Rate and Response Predictors to the Pfizer/BioNTech Vaccine in Multiple Myeloma Patients

MYELOMA NEWS - August 04, 2021

There are currently three Covid-19 vaccines (Pfizer/BioNTech, Moderna, Johnson & Johnson) approved by the US Food and Drug Administration for emergency use ... Read More

Using A Simple Test Called Mass-Fix to Predict Multiple Myeloma Survival

MYELOMA NEWS - August 03, 2021

A new blood-based, inexpensive test could help predict survival for multiple myeloma patients. The Mass-Fix test was created by the Mayo Clinic. We... Read More

What to Pair with Bispecific Antibodies in Multiple Myeloma

MYELOMA NEWS - August 02, 2021

A significant number of bispecific antibodies are being developed for multiple myeloma, going after a variety of targets including BCMA. The bispecific antibodi... Read More

FDA Alert for Pepaxto (melflufen) in Multiple Myeloma

MYELOMA NEWS - July 29, 2021

The Myeloma Crowd by HealthTree occasionally posts results of clinical studies of interest to our family of myeloma patients and caregivers. Myeloma trials... Read More

Fresh Hope for Those With Chronic Graft vs. Host Disease

MYELOMA NEWS - July 28, 2021

Chronic graft versus host disease (cGvHD) is a complication that can occur in about 50% of patients following allo-stem cell transplant. Most cases are mild to ... Read More

Iberdomide: A Potent New Drug to Treat Revlimid/Pomalyst Resistant Myeloma

MYELOMA NEWS - July 07, 2021

Most multiple myeloma patients will take Revlimid or Pomalyst at some point in their treatment, but many patients can become resistant to these immunomodulators... Read More

Thanks to our Myeloma Crowd Community sponsors:

.                         .